Yahoo Canada Web Search

Search results

1. www.roche.com › media › releasesRoche - Doing now what patients need next

   www.roche.com › media › releases

   • Cached

   1 day ago · Roche - Doing now what patients need next

2. www.bloomberg.com › news › articlesRoche to Halt Lung Cancer Drug Study in Fresh Setback

   www.bloomberg.com › news › articles

   • Cached

   2 days ago · 1:50. Roche Holding AG will halt a study of a potential blockbuster drug after it performed worse than existing therapy in lung cancer, marking a fresh research setback for the Swiss drugmaker ...

3. www.reuters.com › business › healthcareRoche to halt trial in latest setback for lung cancer ...

   www.reuters.com › business › healthcare

   2 days ago · BERLIN, July 4 (Reuters) - Roche (ROG.S) will end a lung cancer trial testing its new immunotherapy after the drug did not show a benefit over established treatment Keytruda by Merck & Co (MRK.N ...

4. Videos

   • 

     1:06

     youtube.com

     Roche in 60 seconds

     Jun 4, 2020

     86.6K Views

   • 

     2:04

     youtube.com

     This is the story of Roche

     Jul 6, 2016

     163.2K Views

   • 

     14:50

     youtube.com

     Beware This VIRAL SERUM - La Roche-Posay Mela B3 Review

     Jun 11, 2024

     10.8K Views

   View all

5. www.globenewswire.com › news-release › 2024/07/05FDA approves Roche’s Vabysmo prefilled syringe (PFS) for

   www.globenewswire.com › news-release › 2024/07/05

   • Cached

   1 day ago · Roche Global Media Relations Phone: +41 61 688 8888 / e-mail: media.relations@roche.com. Hans Trees, PhD Phone: +41 79 407 72 58: Sileia Urech Phone: +41 79 935 81 48: Nathalie Altermatt

6. seekingalpha.com › news › 4122321-anti-tigitAnti-TIGIT developers fall after Roche's trial setback

   seekingalpha.com › news › 4122321-anti-tigit

   1 day ago · Roche's (RHHBY) lung cancer drug tiragolumab fails in a clinical trial, hurting the shares of its rival anti-TIGIT developers, Compugen and Arcus. Read more here.

7. www.fiercebiotech.com › biotech › roche-stopsRoche stops pivotal TIGIT trial after Keytruda lands knockout ...

   www.fiercebiotech.com › biotech › roche-stops

   • Cached

   2 days ago · Keytruda has beaten Roche’s TIGIT drug candidate at the first interim analysis of a phase 2/3 lung cancer trial, prompting the Swiss drugmaker to stop the study and consider changes to the ...

8. www.morningstar.com › news › dow-jonesRoche to Halt Lung Cancer Trial After Results Miss Goals

   www.morningstar.com › news › dow-jones

   • Cached

   3 days ago · Provided by Dow Jones. Jul 4, 2024 5:35am. By Adria Calatayud. Roche Holding said it plans to halt a mid- and late-stage clinical study for a combination of drugs to treat lung cancer after it ...

9. People also ask

   What does Roche do?

   • 1 Uwe Kritzler, Thorsten Ulbricht, Philipp Sutter Oct 18 th 2017 Roche Overview 2 Roche - a global pioneer in pharmaceuticals and diagnostics 3 Advancing science to improve people’s lives since 1896 Focused on innovative tests and medicines

   F. Hoffmann-La Roche - OSIsoft

   cdn.osisoft.com/osi/presentations/2017-uc-emea-london/UC17EU-D2LS05-FHoffmann-LaRoche-Kritzler-An-Overview-into-Roche-PI-System-Journey.pdf

   See all results for this question

   Why did Roche end a lung cancer trial?

   • REUTERS/Arnd Wiegmann/File Photo Purchase Licensing Rights BERLIN, July 4 (Reuters) - Roche (ROG.S) will end a lung cancer trial testing its new immunotherapy after the drug did not show a benefit over established treatment Keytruda by Merck & Co (MRK.N), casting further doubt on the drug candidate pioneered by the Swiss company.

   Roche to halt trial in latest setback for lung cancer immunotherapy

   www.reuters.com/business/healthcare-pharmaceuticals/roche-halt-trial-latest-setback-lung-cancer-immunotherapy-2024-07-04/

   See all results for this question

   What is Roche Pred?

   • Pharma Research and Early Development (Roche pRED) is one of four divisions within the Roche Group. The range of research topics are covered by the Discovery & Translational Medicine Areas (DTAs) at Roche pRED focusing on immunology, infectious diseases and ophthalmology, neuroscience and rare diseases; and oncology.

   Strategy Study: How Roche Grew Through Research & Development

   www.cascade.app/strategy-factory/studies/roche-strategy-study

   See all results for this question

   Where is Roche located?

   • Headquartered in Basel Switzerland, Roche employs over 85 000 people globally and sells its products in over 150 countries. Our multinational presence reinforces our ability to offer our healthcare solutions worldwide and to anticipate needs in all regions of the world.

   Company Profile | Roche SA

   www.roche.co.za/en/about-us/company-profile.html

   See all results for this question